# TIGAR maintains intestinal epithelial regeneration by stabilizing HMGCL and promoting β-catenin β-hydroxybutyrylation in burn-induced sepsis

**Authors:** Panyang Zhang, Dan Wu, Yan Wei, Sen Su, Xule Zha, Xiaoyan Liu, Ting Zhang, Qianying Huang, Qian Chen, Zhongwei Bao, Shijun Fan, Lin Xia, Xi Peng

PMC · DOI: 10.1038/s41419-026-08486-7 · Cell Death & Disease · 2026-02-19

## TL;DR

TIGAR helps maintain intestinal health during burn-induced sepsis by boosting ketone production and cell regeneration.

## Contribution

TIGAR's novel role in stabilizing HMGCL and promoting β-catenin β-hydroxybutyrylation is identified.

## Key findings

- TIGAR deficiency reduces BHB production and impairs intestinal stem cell function.
- TIGAR stabilizes HMGCL by blocking Park2-mediated degradation, enhancing BHB synthesis.
- BHB promotes β-catenin β-hydroxybutyrylation, enhancing cell proliferation and regeneration.

## Abstract

Burn-induced sepsis triggers profound intestinal injury, contributing to systemic inflammation and organ damage. Beta-hydroxybutyrate (BHB), a major ketone body, acts as a key regulator of intestinal epithelial regeneration. Its metabolic dysregulation has been implicated in impaired cell proliferation and the maintenance of intestinal stem cells (ISCs). However, the dynamic regulatory mechanisms underlying BHB fluctuation during burn sepsis-induced intestinal injury remain elusive. In this study, we demonstrate that TIGAR expression is markedly reduced in small intestinal crypts of burn sepsis mice. TIGAR deficiency substantially diminishes BHB production and compromises cell proliferation and ISC self-renewal capacity. Mechanistically, the 1-131 domain of TIGAR orchestrate dual functionality: it acts as a mitochondrial targeting signal to direct TIGAR localization and competitively binds the ketogenic enzyme HMGCL, thereby inhibiting its interaction with the E3 ubiquitin ligase Park2. This spatial interference blocks Park2-mediated K48-linked ubiquitination and proteasomal degradation of HMGCL, and stabilizing HMGCL to enhance BHB synthesis. Elevated BHB induces β-hydroxybutyrylation at lysine 335 of β-catenin, which facilitates β-catenin nuclear translocation and strengthens its interaction with TCF4, therefore driving cell proliferation and ISC self-renewal, ultimately maintaining intestinal epithelial regeneration. Collectively, this study identifies a novel role of TIGAR in maintaining intestinal barrier regeneration by promoting ketone body production. This previously unexplored mechanism of TIGAR may serve as a critical compensation for the treatment of burn-related gut barrier dysfunction.

## Linked entities

- **Genes:** TIGAR (TP53 induced glycolysis regulatory phosphatase) [NCBI Gene 57103], HMGCL (3-hydroxy-3-methylglutaryl-CoA lyase) [NCBI Gene 3155], PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071], ctnnb1.S (catenin beta 1 S homeolog) [NCBI Gene 380441], TCF4 (transcription factor 4) [NCBI Gene 6925]
- **Proteins:** TIGAR (TP53 induced glycolysis regulatory phosphatase), HMGCL (3-hydroxy-3-methylglutaryl-CoA lyase), PRKN (parkin RBR E3 ubiquitin protein ligase), ctnnb1.S (catenin beta 1 S homeolog), TCF4 (transcription factor 4)
- **Chemicals:** Beta-hydroxybutyrate (PubChem CID 441)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** MUL1 (mitochondrial E3 ubiquitin protein ligase 1) [NCBI Gene 79594] {aka C1orf166, GIDE, MAPL, MULAN, RNF218}, Hmgcl (3-hydroxy-3-methylglutaryl-Coenzyme A lyase) [NCBI Gene 15356] {aka HL}, Bdh1 (3-hydroxybutyrate dehydrogenase 1) [NCBI Gene 117099] {aka Bdh}, Ctnnb1 (catenin beta 1) [NCBI Gene 84353] {aka Catnb}, Pcna (proliferating cell nuclear antigen) [NCBI Gene 25737] {aka PCNAR, Pcna/cyclin}, Fbl (fibrillarin) [NCBI Gene 14113] {aka FIB, FLRN, RNU3IP1}, Tigar (TP53 induced glycolysis regulatory phosphatase) [NCBI Gene 502894], TIGAR (TP53 induced glycolysis regulatory phosphatase) [NCBI Gene 57103] {aka C12orf5, FR2BP}, Tcf4 (transcription factor 4) [NCBI Gene 84382], Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, Epidermal Growth Factor [NCBI Gene 108348113], Tcf4 (transcription factor 4) [NCBI Gene 21413] {aka 5730422P05Rik, ASP-I2, E2-2, E2.2, ITF-2, ITF-2b}, Fbl (fibrillarin rRNA 2'-O-methyltransferase) [NCBI Gene 292747], Cldn3 (claudin 3) [NCBI Gene 12739] {aka Cpetr2, mRVP1}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Hmgcl (3-hydroxy-3-methylglutaryl-CoA lyase) [NCBI Gene 79238], Vil1 (villin 1) [NCBI Gene 22349] {aka Vil}, Pcna (proliferating cell nuclear antigen) [NCBI Gene 18538], Lgr5 (leucine rich repeat containing G protein coupled receptor 5) [NCBI Gene 14160] {aka FEX, Gpr49}, Mul1 (mitochondrial ubiquitin ligase activator of NFKB 1) [NCBI Gene 68350] {aka 0610009K11Rik, Gide, Tnrip-1}, HMGCL (3-hydroxy-3-methylglutaryl-CoA lyase) [NCBI Gene 3155] {aka HL, HMGCL1}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16476] {aka AP-1, Junc, c-jun}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Tomm20 (translocase of outer mitochondrial membrane 20) [NCBI Gene 67952] {aka 1810060K07Rik, Gm19268, MAS20, MOM19, TOM20, mKIAA0016}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Hmgcs2 (3-hydroxy-3-methylglutaryl-CoA synthase 2) [NCBI Gene 24450] {aka Hmgcs1, Mt3h3mg}, Prkn (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 50873] {aka Park2}, Actb (actin, beta) [NCBI Gene 81822] {aka Actx}, Lgr5 (leucine rich repeat containing G protein coupled receptor 5) [NCBI Gene 299802] {aka Gpr49}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Tigar (Trp53 induced glycolysis regulatory phosphatase) [NCBI Gene 319801] {aka 9630033F20Rik}
- **Diseases:** MODS (MESH:D009102), Burn (MESH:D002056), analgesia (MESH:D000699), cervical dislocation (MESH:D002575), metabolic disorder (MESH:D008659), organoid growth disorder (MESH:D006130), Trauma (MESH:D014947), inflammation (MESH:D007249), Chemical Poisoning (MESH:D011041), organ damage (MESH:D000092124), mucosal damage (MESH:D052016), Sepsis (MESH:D018805), Intestinal damage (MESH:D007410), scald injuries (MESH:D013206), gut injury (MESH:C536735), deaths (MESH:D003643), burn wound infection (MESH:D014946), cytotoxicity (MESH:D064420), enterogenous infections (MESH:D007239)
- **Chemicals:** Trizol (MESH:C411644), MG132 (MESH:C072553), CCK8 (MESH:D012844), water (MESH:D014867), BS (MESH:D001895), GlutaMAX (MESH:C054122), Ketone bodies (MESH:D007657), SDS (MESH:D012967), ACN (MESH:C084683), HCl (MESH:D006851), EDU (MESH:C022811), DTT (MESH:D004229), methanol (MESH:D000432), NaCl (MESH:D012965), BHB (MESH:D020155), Rapamycin (MESH:D020123), streptomycin (MESH:D013307), pentose phosphate (MESH:D010428), acetonitrile (MESH:C032159), Triton X-100 (MESH:D017830), IP (MESH:C041508), ketone (MESH:D007659), EDTA (MESH:D004492), PTM (MESH:D010646), xylazine (MESH:D014991), His (MESH:D006639), N2 (MESH:D009584), NP-40 (MESH:C010615), lactate (MESH:D019344), agarose (MESH:D012685), polybrene (MESH:D006583), LPS (MESH:D008070), paraformaldehyde (MESH:C003043), CO2 (MESH:D002245), Pen (MESH:C058388), glucose (MESH:D005947), DAPI (MESH:C007293), PVDF (MESH:C024865), CHX (MESH:D003513), buprenorphine (MESH:D002047), PBS (MESH:D007854), puromycin (MESH:D011691), penicillin (MESH:D010406), HEPES (MESH:D006531), HMG-CoA (MESH:C008047), crystal violet (MESH:D005840), Y27632 (MESH:C108830), Cy3 Goat (-), fatty acid (MESH:D005227), acetone (MESH:D000096), ammonium bicarbonate (MESH:C027043), acetoacetate (MESH:C016635), TFA (MESH:D014269), NADPH (MESH:D009249), Hoechst 33342 (MESH:C017807), MgSO4 (MESH:D008278)
- **Species:** Mycoplasma (genus) [taxon 2093], Mus musculus (house mouse, species) [taxon 10090], Pseudomonas aeruginosa (species) [taxon 287], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** C with 5, K335R, K335
- **Cell lines:** hiec-6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), CCK8 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_2873), pLKO.1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB), E- — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z894), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), IEC-6 — Rattus norvegicus (Rat), Finite cell line (CVCL_0343), S3N-P — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_2938), HIEC-6 — Homo sapiens (Human), Finite cell line (CVCL_6C21)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949245/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949245/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949245/full.md

---
Source: https://tomesphere.com/paper/PMC12949245